| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R6J2 | T-cell leukemia/lymphoma 6, isoform CRA_d; | TCL6; | NULL | 163 | human |
| B2WTI3 | Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6; Phosphatidylserine receptor transcript variant 1; Phosphatidylserine receptor, isoform CRA_d; | JMJD6; PTDSR; | NULL | 335 | human |
| A0A024RB26 | HCG2040070, isoform CRA_a; | NULL | NULL | 48 | human |
| A0A024R6K4 | HCG1649783, isoform CRA_b; | NULL | NULL | 55 | human |
| A0A087WY60 | Pre-mRNA-splicing factor CWC25 homolog; | CWC25; | NULL | 68 | human |
| H0UI08 | Interphotoreceptor matrix proteoglycan 1, isoform CRA_a; | IMPG1; | NULL | 579 | human |
| H0UIC3 | Neurofibromin 1 (Neurofibromatosis, von Recklinghausen disease, Watson disease), isoform CRA_a; | NF1; | NULL | 1554 | human |
| A0A024RAW5 | Serine/threonine kinase 38 like, isoform CRA_b; | STK38L; | NULL | 264 | human |
| Q6ZYK7 | Prostaglandin G/H synthase 2; Putative cyclooxygenase-2; | COX-2; PTGS2; | NULL | 163 | human |
| A0A024R1X6 | Keratin 14 (Epidermolysis bullosa simplex, Dowling-Meara, Koebner), isoform CRA_a; | KRT14; | NULL | 261 | human |
| A0A024R9Q0 | Chromosome 9 open reading frame 102, isoform CRA_a; | C9orf102; | NULL | 320 | human |
| A0A024R2T1 | Glutathione peroxidase 1; | GPX1; | NULL | 47 | human |
| I3L208 | HCG1644378, isoform CRA_a; Oxidoreductase-like domain-containing protein 1; | OXLD1; | NULL | 92 | human |
| F5GWT2 | Programmed cell death protein 2; | PDCD2; | NULL | 99 | human |
| O14835 | Dim1p homolog; Thioredoxin-like 4A, isoform CRA_a; Thioredoxin-like protein 4A; | TXNL4A; | NULL | 91 | human |
| A0A059RIS0 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| A0A024RC22 | HCG2036562, isoform CRA_a; | NULL | NULL | 27 | human |
| Q5JZB7 | Spindlin-2B; Spindlin-like protein 2, isoform CRA_b; | SPIN2B; SPIN-2; | NP_001269390.1;NP_001269391.1; | 157 | human |
| A0A024RA18 | HCG2011575, isoform CRA_a; | NULL | NULL | 55 | human |
| A0A024R8T3 | Acyl-coenzyme A oxidase; | ACOX1; | NULL | 660 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |